As we wrap up the 2025 Egnyte Life Sciences Summit, please join us as we reflect on the key insights, innovations, and strategies shared throughout the day. This session will highlight what Egnyte is doing right now to help firms enhance collaboration with sponsors, CROs, and regulatory teams. We will also discuss our commitment to ensuring compliance with ICH E6(R3), FDA 21 CFR Part 11, and GxP regulations and explore how to prepare for the next wave of AI-powered intelligence.